| Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies W Alduaij, A Ivanov, J Honeychurch, EJ Cheadle, S Potluri, SH Lim, ... Blood, The Journal of the American Society of Hematology 117 (17), 4519-4529, 2011 | 353 | 2011 |
| Presentation and management of intravascular large B-cell lymphoma K Shimada, T Kinoshita, T Naoe, S Nakamura The lancet oncology 10 (9), 895-902, 2009 | 307 | 2009 |
| Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan K Shimada, K Matsue, K Yamamoto, T Murase, N Ichikawa, M Okamoto, ... Journal of Clinical Oncology 26 (19), 3189-3195, 2008 | 307 | 2008 |
| Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance J Hiraga, A Tomita, T Sugimoto, K Shimada, M Ito, S Nakamura, H Kiyoi, ... Blood, The Journal of the American Society of Hematology 113 (20), 4885-4893, 2009 | 295 | 2009 |
| Target antigen density governs the efficacy of anti–CD20-CD28-CD3 ζ chimeric antigen receptor–modified effector CD8+ T cells K Watanabe, S Terakura, AC Martens, T Van Meerten, S Uchiyama, ... The Journal of Immunology 194 (3), 911-920, 2015 | 291 | 2015 |
| Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan T Tokunaga, K Shimada, K Yamamoto, D Chihara, T Ichihashi, R Oshima, ... Blood, The Journal of the American Society of Hematology 119 (12), 2837-2843, 2012 | 146 | 2012 |
| Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas K Kataoka, H Miyoshi, S Sakata, A Dobashi, L Couronné, Y Kogure, ... Leukemia 33 (7), 1687-1699, 2019 | 129 | 2019 |
| Central nervous system involvement in intravascular large B‐cell lymphoma: a retrospective analysis of 109 patients K Shimada, T Murase, K Matsue, M Okamoto, N Ichikawa, N Tsukamoto, ... Cancer science 101 (6), 1480-1486, 2010 | 129 | 2010 |
| Biology and management of primary effusion lymphoma K Shimada, F Hayakawa, H Kiyoi Blood, The Journal of the American Society of Hematology 132 (18), 1879-1888, 2018 | 97 | 2018 |
| Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis K Shimada, T Yokozawa, Y Atsuta, A Kohno, F Maruyama, K Yano, H Taji, ... Bone marrow transplantation 36 (2), 115-121, 2005 | 93 | 2005 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular … K Shimada, M Yamaguchi, Y Atsuta, K Matsue, K Sato, S Kusumoto, ... The Lancet Oncology 21 (4), 593-602, 2020 | 80 | 2020 |
| Nodal T/NK‐cell lymphoma of nasal type: a clinicopathological study of six cases E Takahashi, N Asano, C Li, T Tanaka, K Shimada, S Shimada, T Yoshino, ... Histopathology 52 (5), 585-596, 2008 | 71 | 2008 |
| Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo S Noguchi, J Iwasaki, M Kumazaki, T Mori, K Maruo, H Sakai, N Yamada, ... Molecular Therapy 21 (6), 1204-1211, 2013 | 64 | 2013 |
| Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan T Tanaka, K Shimada, K Yamamoto, Y Hirooka, Y Niwa, I Sugiura, ... Annals of hematology 91, 383-390, 2012 | 57 | 2012 |
| Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomography K Shimada, H Kosugi, S Shimada, H Narimatsu, Y Koyama, N Suzuki, ... International journal of hematology 88, 149-153, 2008 | 57 | 2008 |
| Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma K Shimada, K Yoshida, Y Suzuki, C Iriyama, Y Inoue, M Sanada, ... Blood, The Journal of the American Society of Hematology 137 (11), 1491-1502, 2021 | 56 | 2021 |
| Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective … T Aoki, K Izutsu, R Suzuki, C Nakaseko, H Arima, K Shimada, A Tomita, ... Haematologica 99 (12), 1817, 2014 | 56 | 2014 |
| High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma T Aoki, K Shimada, R Suzuki, K Izutsu, A Tomita, Y Maeda, J Takizawa, ... Blood cancer journal 5 (12), e372-e372, 2015 | 55 | 2015 |
| Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation T Sugimoto, A Tomita, J Hiraga, K Shimada, H Kiyoi, T Kinoshita, T Naoe Biochemical and biophysical research communications 390 (1), 48-53, 2009 | 55 | 2009 |
| Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells A Sakamoto, S Kunou, K Shimada, M Tsunoda, T Aoki, C Iriyama, ... Cancer science 110 (1), 269-278, 2019 | 47 | 2019 |
Dai ChiharaMD Anderson Cancer Center在 umin.ac.jp 的电子邮件经过验证
Dai ChiharaMD Anderson Cancer Center在 umin.ac.jp 的电子邮件经过验证